glp-1/gip dual agonist mechanism of action Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements The Effects of Dual GLP-1/GIP

SAN DIEGO(March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity

Compounded GLP-1 drugs are going away Suggested Caption: The shortage of name-brand GLP-1 drugs has ended, and less expensive compounded GLP-1 drugs will no longer be available

Yet, data on their safety and clinical utility during these reproductive windows remain limited

How retatrutide works: the first triple agonist targeting GIP, GLP-1, and glucagon receptors

Heres what research and medical experts say they canand cantdo.

Over 30 years ago scientists discovered the potential of Gila monster venom as a treatment for type 2 diabetes.